Redwood Investment Management’s AstraZeneca AZN Stock Holding History

Redwood Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$450K	Hold	2,373	–	–	0.04%	273
2026 Q1	$468K	Sell	2,373 -1	-0%	-$193	0.06%	235
2025 Q4	$436K	Sell	2,374 -32	-1%	-$5.61K	0.05%	268
2025 Q3	$369K	Buy	2,406 +47	+2%	+$7.11K	0.04%	251
2025 Q2	$330K	Hold	2,359	–	–	0.04%	256
2025 Q1	$347K	Buy	2,359 +32	+1%	+$4.63K	0.04%	252
2024 Q4	$305K	Hold	2,327	–	–	0.03%	292
2024 Q3	$362K	Sell	2,327 -4	-0.2%	-$646	0.03%	294
2024 Q2	$364K	Buy	2,331 +18	+0.8%	+$2.71K	0.03%	300
2024 Q1	$313K	Buy	+2,313	New	+$306K	0.03%	300

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Redwood Investment Management's AZN Position: Q2 2026 in Review

Redwood Investment Management held its AstraZeneca (AZN) position steady in Q2 2026 at 2,373 shares worth $450K. The position accounts for 0.04% of the portfolio, ranked #273.

Redwood Investment Management first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. The position peaked at $468K in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Redwood Investment Management held 2,373 shares of AstraZeneca worth $450K as of Q2 2026.
Redwood Investment Management left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.04% of Redwood Investment Management's portfolio in Q2 2026, its #273 holding.
Redwood Investment Management first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
Redwood Investment Management's AstraZeneca position peaked at $468K in Q1 2026.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Redwood Investment Management's 13F filing for Q2 2026, filed 17 Aug 2026.